Oseni Interactions
There are 426 drugs known to interact with Oseni (alogliptin/pioglitazone), along with 12 disease interactions, and 5 alcohol/food interactions. Of the total drug interactions, 11 are major, 395 are moderate, and 20 are minor.
- View all 426 medications that may interact with Oseni
- View Oseni alcohol/food interactions (5)
- View Oseni disease interactions (12)
Most frequently checked interactions
View interaction reports for Oseni (alogliptin / pioglitazone) and the medicines listed below.
- Abilify (aripiprazole)
- albuterol
- allopurinol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- carvedilol
- clindamycin
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Farxiga (dapagliflozin)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flomax (tamsulosin)
- gabapentin
- glipizide
- Invokana (canagliflozin)
- Januvia (sitagliptin)
- Jardiance (empagliflozin)
- lisinopril
- Lyrica (pregabalin)
- metformin
- Nexium (esomeprazole)
- omeprazole
- simvastatin
- Synthroid (levothyroxine)
- tamsulosin
- tramadol
- trazodone
- zolpidem
Oseni alcohol/food interactions
There are 5 alcohol/food interactions with Oseni (alogliptin / pioglitazone).
Oseni disease interactions
There are 12 disease interactions with Oseni (alogliptin / pioglitazone) which include:
- CHF
- type I diabetes
- liver disease
- renal dysfunction
- pancreatitis
- bladder cancer
- edema
- liver disease
- macular edema
- premenopausal anovulation
- weight gain
- anemia
Report options
QR code containing a link to this page
More about Oseni (alogliptin / pioglitazone)
- Oseni consumer information
- Compare alternatives
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
